Efficacy and Safety of Traditional Chinese Medicine Intervention for Women With Menopausal Syndrome

G

Guangzhou University of Traditional Chinese Medicine

Status and phase

Completed
Phase 3

Conditions

Menopausal Syndrome

Treatments

Other: TCM intervention
Other: Western intervention

Study type

Interventional

Funder types

Other

Identifiers

NCT00933725
2007BAI20B014 (Other Identifier)

Details and patient eligibility

About

The purpose of this multiple-centered, randomized, controlled study is to investigate the efficacy and safety of a combination using herbs prescription and traditional Chinese medicine (TCM) emotion treatment in women with menopausal syndrome.

Full description

Menopausal syndrome is a high incident disease which is associated with great influence in women's health and quality of life. It involves physical discomforts and emotional symptoms. Traditional Chinese medicine (TCM) theory emphasizes treating physical and emotional symptoms simultaneously viewing one person as an entirety. Herbs prescription and TCM emotion treatment is effective and safe to treat women with menopausal syndrome in clinical practice.

Enrollment

194 patients

Sex

Female

Ages

41 to 60 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Aged 41-60;
  • Amenorrhea for at least 6 months;
  • Menstruation dysfunction or cessation because of age or bilateral ovariectomy;
  • Hot flushes and night sweats symptoms;
  • Vaginal secretion decreased with or without dyspareunia;
  • Kupperman Index (KI) score ≥ 15;
  • Self-rating Anxiety Scale or Self-rating Depression Scale standard score >50,but <72(standard score= scale score ×1.25);
  • FSH ≥ 20 IU/L;
  • Thickness of endometrium ≤0.5cm if Amenorrhea for at least 12 months;or ≤1.5cm if Amenorrhea for 6 months to 12 months;
  • Meet the diagnosis criteria of TCM syndrome of liver stagnation and kidney deficiency.

Exclusion criteria

  • With malignant tumor in reproductive system;
  • With benign tumor in reproductive system and need surgery;
  • Malignant tumor in mammary gland;
  • Irregular vaginal bleeding for unknown reasons;
  • Thickness of endometrium ≥1.5cm by ultrasound examination;
  • Have used Sex hormone medicine or joined other clinical trials 3 months before;
  • Allergy;
  • Severe diseases (eg., of the cardiovascular, liver, kidney) or uncontrolled endocrine diseases (eg., diabetes mellitus, hyperthyreosis )
  • Severe psychiatric disease diagnosed by psychiatric physician;
  • Refuse informed consent.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

194 participants in 2 patient groups

TCM intervention
Experimental group
Description:
Particle of compound Chinese herbs and TCM emotion treatment and tablet placebo of Tibolone
Treatment:
Other: TCM intervention
Western intervention
Active Comparator group
Description:
Tibolone and supportive psychotherapy and Particle placebo of compound Chinese herbs
Treatment:
Other: Western intervention

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location

Resources

© Copyright 2024 Veeva Systems